nse,bse,nseindia,nse india,share price,stock price,stock value,shares prices,share prices,stock quote,stock prices, share prices, corporate announcements,board meetings,corporate actions,dividends,agm,stock split,bonus

Biocon Limited (NSE India Code : BIOCON) BUY

Company Name :

Enter Company Name or NSE Code

BIOCON Technical Levels

Resistance 2		291.70
Resistance 1		288.90
PIVOT		286.95
Support 1		284.15
Support 2		279.40

BIOCON Fundamentals

Earning Growth		-22.05%
Profit Margin		26.92
PE		10.64
EPS		21.88
Quarter		30-Sep-11

BIOCON Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size		1000

BIOCON Options

Most Active Call		290
Most Active Put		280
Highest OI Call		300
Highest OI Put		260
Expiry Date		19-Oct-12

BIOCON Technical Levels

Other Stocks from Pharmaceuticals Sector AARTIDRUGS ABBOTINDIA AJANTPHARM ALCHEM ALKALI ALPA AMRUTANJAN ANKURDRUGS ARL ASTRAZEN AUROPHARMA AVENTIS BALPHARMA BIOCON BLISSGVS CADILAHC CELESTIAL CIPLA DISHMAN DIVISLAB DRREDDY ELDERPHARM FDC FKONCO GLAXO GLENMARK GRANULES INDOCO INDSWFTLAB INDSWFTLTD IPCALAB JAGSNPHARM JBCHEPHARM JUBILANT KILITCH KOPRAN LUPIN LYKALABS MANGALAM MERCK MOREPENLAB NATCOPHARM NECLIFE NEULANDLAB OPTOCIRCUI ORCHIDCHEM PANACEABIO PARABDRUGS PFIZER PIRHEALTH

Sponsored Advertisement

BIOCON Share Price on 5-10-2012

Open		284
High		284
Low		271.55
Close		273.4
Volume		267464
Change		-7.25 (-2.58%)

Series		EQ
Date of Listing		07-Apr-04
Paid Up Value		5
Face Value		5
Market Capital		1934.68 Crores
52 Week High/Low		368.7 / 207.9

Sponsored Advertisement

Biocon Limited Company Profile

Biocon, incorporated at Bangalore, India in 1978, is a fully integrated biotechnology enterprise focused on biopharmaceuticals, custom research, clinical research and enzymes. The company was promoted as a joint venture with Ireland-based MNC Biocon Biochemicals. Later, Unilever acquired Biocon Biochemical`s stake in 1995, but sold it to the current promoters in 1999. The company has its facilities at Hebbagodi and Bommasandra, Bangalore district, Karnataka and is engaged in manufacture of biotechnological products in the pharmaceutical and enzyme sectors through fermentation based technology. Biocon continues to be the only Indian company to have USFDA qualification for Lovastatin. FDA has inspected and accepted Biocon`s facilities for Simvastatin, Pravastatin, Pioglitazone HCl, Lovastatin (submerged fermentation). It has commercialized human insulin (rDNA) based on Pichia expression system. Biocon has also submitted the `Drug Master` file for the same with USFDA. The company has a a couple of subsidiary companies namely, Syngene International, which is into chemistry and molecular-based custom research services in early stage drug discovery and development and Clinigene International, which offers longitudinal research in diabetes with comprehensive services in drug development and clinical trials. Also, the company has invested in a joint venture called Biocon Biopharmaceuticals. The company plans to focus on monoclonal antibodies as part of Biocon`s fermentation business, research areas of new drug discovery, clinical development of existing pipeline of biologicals, strategic collaborations and continued R&D capabilities in biologics.

BIOCON Intraday Realtime Chart

BIOCON Corporate Announcements

DATE	PURPOSE
31-Jul-12	Updates
27-Jul-12	Date of payment of dividend
27-Jul-12	Proceedings of Annual General Meeting
26-Jul-12	Press Release
26-Jul-12	Results Update%2c Quarter ended%2c 30-JUN-2012 (Standalone)

BIOCON Corporate Actions

DATE	PURPOSE
05-Jul-12	Annual General Meeting / Dividend Rs 5 Per Share
05-Jul-12	AGM/DIV RS 5 PER SHRE
07-Jul-11	Annual General Meeting/Dividend Rs 3 Per Share
07-Jul-11	AGM/DIV RS 3 PER SHARE
05-May-11	Interim Dividend-Rs.1.50 Per Share (Purpose Revised)

BIOCON Board Meetings

MEETING DATE	PURPOSE
25-Jul-12	Results/Others
26-Apr-12	Results/Dividend
24-Jan-12	Un-audited Financial Results
20-Oct-11	Un-audited Financial Results
19-Oct-11	Board meeting Rescheduled

BIOCON Related companies

Symbol	Company Name
AARTIDRUGS	Aarti Drugs Limited
ABBOTINDIA	Abbott India Limited
AJANTPHARM	Ajanta Pharma Limited
ALCHEM	Alchemist Limited
ALKALI	Alkali Metals Limited

Most Active NSE INDIA Stocks

HDFC LITL IVRCLINFRA HDIL UNITECH JPASSOCIAT GVKPIL TATAMOTORS IFCI IBREALEST ESSAROIL GMRINFRA BIRLAPOWER HINDALCO BHEL RENUKA RCOM DLF SUZLON RELCAPITAL IDFC ADANIENT ITC TATAPOWER BALLARPUR

Free Stock Market Tips:

What is Investor Protection Fund (IPF)/ Customer Protection Fund (CPF) at Stock Exchanges?

Home	Stock Market	IPO	Mutual Funds	Education	Paid Service
About us	Share Market	IPO Watch	MF News	IPO	Subscription
VJonDalalStreet	Technical Analysis	New IPO Review	Old Funds	Articles	Equity Performance
DalalStreet Blog	Stock Market News	Indian IPO News	New Funds	Stock Market	Futures Performance
Free Sms Alerts	World Stock Market	IPO Allotment Status	Best Funds	Financial Terms	Options Performance
Privacy	Stock Recommendations	Grey Market Premium	MF Analysis	Futures & Options	Jackpot Performance

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer